CENTOGENE’s mission is to provide data-driven, life-changing answers to patients, physicians, and pharma companies for rare and neurodegenerative diseases. We integrate multiomic technologies with the CENTOGENE Biodatabank – providing dimensional analysis to guide the next generation of precision medicine. Our unique approach enables rapid and reliable diagnosis for patients, supports a more precise physician understanding of disease states, and accelerates and de-risks targeted pharma drug discovery, development, and commercialization.
Industry
Biotechnology Research, Corona-Schnelltests, Arzneimittel, Corona Antigen-Schnelltests, Medizinische Diagnostik, Schnelltests, Pharmazeutische Erzeugnisse (Arzneimittel), Antigenschnelltests, Unknown
HQ Location
Am Strande 7
Rostock, Mecklenburg-West Pomerania 18055, DE
Keywords
Biochemical diagnostic testGenetic diagnostic testRare diseasesCongenital diseasesOncogeneticsClinical and medical interpretation of genetic dataNext Generation SequencingBiomarkercovid19Whole Exome Seguencing (WES)